Table 2.
Risk of bias in human trials examining yohimbine in alcohol research.
| Selection bias | Performance bias | Detection bias | Attrition bias | Reporting bias | Other bias | ||
|---|---|---|---|---|---|---|---|
| Random sequence generation | Allocation concealment | ||||||
| Krystal et al. 1994 | |||||||
| Ranking | Low-risk | Low-risk | Low-risk | Low-risk | Low-risk | Low-risk | |
| Krystal et al. 1996 | |||||||
| Ranking | Low-risk | Low-risk | Low-risk | Low-risk | High-risk | Low-risk | |
| Krystal et al. 1997 | |||||||
| Ranking | Low-risk | Low-risk | Low-risk | Low-risk | Low-risk | High-risk | |
| McDougle et al. 1995 | |||||||
| Ranking | Low-risk | Low-risk | Low-risk | Low-risk | Low-risk | Low-risk | Unclear |
| Umhau et al. 2011 | |||||||
| Ranking | Low-risk | Low-risk | Low-risk | Low-risk | Low-risk | Low-risk | Low-risk |
Clinical trials were assessed for selection, performance, detection, attrition, reporting biases, and described as high-risk, low-risk, or unclear [29].